A new diagnosis of borderline lepromatous leprosy was established in a man who had immigrated to Kentucky from Mexico. He was placed on a World Health Organization treatment regimen consisting of dapsone, clofazimine, and rifampin. The biology of leprosy, its diagnosis, treatment, and worldwide impact are reviewed. Because of the potential for highly mobile populations to export endemic diseases, Kentucky physicians must expand their lists of differential diagnoses.

[No Keywords available]

hospitalization Follow-Up Studies follow up human risk assessment Kentucky borderline leprosy Leprosy, Borderline Hispanic Americans United States Humans Hispanic Treatment Outcome Severity of Illness Index male case report isolation and purification needle biopsy Article Drug Therapy, Combination Biopsy, Needle adult migration leprostatic agent Leprostatic Agents Emigration and Immigration Mycobacterium leprae antiinfective agent Anti-Bacterial Agents drug combination